claim: fda authorizes another diagnostic test for screening of people without known or suspected covid-19 infection
evidence_1: last month, the fda posted updated templates with recommendations for test developers to demonstrate validation for a test to be authorized for screening of asymptomatic people, as well as for sample pooling.", "the fda reissued the labcorp covid-19 rt-pcr test eua to expand use of the test to anyone, after the company provided scientific data showing the tests ability to detect sars-cov-2 in a general, asymptomatic population.", "additionally, the data reviewed by the fda demonstrated that the test is as accurate in the broader asymptomatic population as it is among people suspected to have covid-19.", 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  "until now, molecular diagnostic tests have generally been authorized for people suspected of having covid-19 by their health care provider, which has allowed asymptomatic people to be tested, when warranted, at the discretion of the health care provider.")